FDA: Stop using 'True Man' or 'Energy Max'

May 10, 2007

The U.S. Food and Drug Administration issued a warning Thursday, advising consumers not to purchase or use "True Man" or "Energy Max" products.

Both products, sold as dietary supplements nationwide, are touted as sexual enhancement products and treatments for erectile dysfunction. But the FDA said the products contain potentially harmful, undeclared ingredients.

Specifically, the FDA said the products contain substances called analogs that have structures similar to active ingredients in approved prescription drugs.

The government agency said consumers should discontinue use of both True Man and Energy Max products since it has not approved either and, therefore, their safety and effectiveness have not been established.

Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research, said the undeclared analogs in True Man and Energy Max might interact with nitrates found in some prescription drugs, such as nitroglycerin and medications used to treat diabetes, high cholesterol and heart disease.

Both products are distributed and packed by America True Man Health Inc. of West Covina, Calif.

Copyright 2007 by United Press International

Explore further: What's happening with your donated specimen?

add to favorites email to friend print save as pdf

Related Stories

Drought sees Rio's main hydro plant turned off

4 hours ago

A major Rio hydroelectric power plant was switched off after water levels slipped below an operational minimum following severe drought, Brazil's national grid told AFP on Thursday.

Recommended for you

Cambodia bans 'virgin surgery' adverts

6 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

21 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.